The contribution of COX-2 mediated angiogenesis to vGPCR tumorigenicity and angiogenicity is indicated by the impairment of tumor growth in Celecoxib treated animals that show significant decrease in tumor neo-vessel formation and maturation, correlated with intratumoral VEGF levels. The gene discussed is VEGFA; the disease is neoplasm.